[(S)-1-((1R,2S,5S)-2-Hydroxymethyl-6,6-dimethyl-3-aza-bicyclo[3.1.0]hexane-3-carbonyl)-2,2-dimethyl-propyl]-carbamic acid tert-butyl ester | 864801-47-8

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: [(S)-1-((1R,2S,5S)-2-Hydroxymethyl-6,6-dimethyl-3-aza-bicyclo[3.1.0]hexane-3-carbonyl)-2,2-dimethyl-propyl]-carbamic acid tert-butyl ester
• 英文别名: tert-butyl N-[(2S)-1-[(1R,2S,5S)-2-(hydroxymethyl)-6,6-dimethyl-3-azabicyclo[3.1.0]hexan-3-yl]-3,3-dimethyl-1-oxobutan-2-yl]carbamate
• CAS: 864801-47-8
• 化学式: C₁₉H₃₄N₂O₄
• 分子量: 354.49
• InChiKey: QUFLIPDDVYWGAG-RFQIPJPRSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.9
• 重原子数：
  25
• 可旋转键数：
  6
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.89
• 拓扑面积：
  78.9
• 氢给体数：
  2
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  [(S)-1-((1R,2S,5S)-2-Hydroxymethyl-6,6-dimethyl-3-aza-bicyclo[3.1.0]hexane-3-carbonyl)-2,2-dimethyl-propyl]-carbamic acid tert-butyl ester 在 chromium(VI) oxide 、 硫酸 、 N,N-二异丙基乙胺 、 N-[(dimethylamino)-3-oxo-1H-1,2,3-triazolo[4,5-b]pyridin-1-yl-methylene]-N-methylmethanaminium hexafluorophosphate 作用下， 以 二氯甲烷 为溶剂， 反应 21.0h， 生成 tert-butyl N-[(2S)-1-[(1R,2S,5S)-2-[[1-cyclopropyl-4-[[2-[[(1S)-2-(dimethylamino)-2-oxo-1-phenylethyl]amino]-2-oxoethyl]amino]-3-hydroxy-4-oxobutan-2-yl]carbamoyl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexan-3-yl]-3,3-dimethyl-1-oxobutan-2-yl]carbamate
  参考文献：
  名称：

  Discovery of SCH446211 (SCH6):  A New Ketoamide Inhibitor of the HCV NS3 Serine Protease and HCV Subgenomic RNA Replication

  摘要：

  Introduction of various modified prolines at P-2 and optimization of the P-1 side chain led to the discovery of SCH6 (24, Table 2), a potent ketoamide inhibitor of the HCV NS3 serine protease. In addition to excellent enzyme potency (K-i* = 3.8 nM), 24 was also found to be a potent inhibitor of HCV subgenomic RNA replication with IC50 and IC90 of 40 and 100 nM, respectively. Recently, antiviral activity of 24 was demonstrated with inhibition of the full-length genotype 2a HCV genome. In addition, 24 was found to restore the responsiveness of the interferon regulatory factor 3 (IRF-3) in cells containing HCV RNA replicons.

  DOI：

  10.1021/jm060077j
• 作为产物：
  描述：

  (1S,4S,5R)-4-(hydroxymethyl)-6,6-dimethyl-3-azabicyclo[3.1.0]hexan-2-one 在 lithium aluminium tetrahydride 、 (benzotriazo-1-yloxy)tris(dimethylamino)phosphonium hexafluorophosphate 、 三乙胺 作用下， 以 四氢呋喃 、 二氯甲烷 为溶剂， 生成 [(S)-1-((1R,2S,5S)-2-Hydroxymethyl-6,6-dimethyl-3-aza-bicyclo[3.1.0]hexane-3-carbonyl)-2,2-dimethyl-propyl]-carbamic acid tert-butyl ester
  参考文献：
  名称：

  包含（1 R，5 S）-6,6-二甲基-3-氮杂双环[3.1.0]己烷-2（S）-羧酸（4），（1 R，5 S）-螺[3 ]的二肽的合成-氮杂双环[3.1.0]己烷-6,1'-环丙烷]-2（S）-羧酸（5）和（1 S，5 R）-6,6-二甲基-3-氮杂双环[3.1.0]己烷-2（S）-羧酸（6）

  摘要：

  描述了结合了3-氮杂双环[3.1.0]己烷系统的二肽的多功能合成方法。

  DOI：

  10.1016/j.tetlet.2006.06.052

文献信息

• [EN] CYCLOBUTENEDIONE GROUPS-CONTAINING COMPOUNDS AS INHIBITORS OF HEPATITIS C VIRUS NS3 SERINE PROTEASE<br/>[FR] GROUPES CYCLOBUTENEDIONE CONTENANT DES COMPOSES SERVANT D'INHIBITEURS A LA SERINE PROTEASE NS3 DU VIRUS DE L'HEPATITE C
  申请人：SCHERING CORP

  公开号：WO2005085197A1

  公开（公告）日：2005-09-15

  The present invention discloses novel compounds which have HCV protease inhibitory activity as well as methods for preparing such compounds. In another embodiment, the invention discloses pharmaceutical compositions comprising such compounds as well as methods of using them to treat disorders associated with the HCV protease.

  本发明公开了具有HCV蛋白酶抑制活性的新化合物，以及制备这种化合物的方法。在另一实施方式中，本发明公开了包含这种化合物的药物组合物，以及使用它们治疗与HCV蛋白酶相关的疾病的方法。
• Novel inhibitors of Hepatitis C virus NS3 protease
  申请人：Bogen L. Stephane

  公开号：US20070142301A1

  公开（公告）日：2007-06-21

  The present invention discloses novel compounds which have HCV protease inhibitory activity as well as methods for preparing such compounds. In another embodiment, the invention discloses pharmaceutical compositions comprising such compounds as well as methods of using them to treat disorders associated with the HCV protease.
• US7205330B2
  申请人：——

  公开号：US7205330B2

  公开（公告）日：2007-04-17
• US7635694B2
  申请人：——

  公开号：US7635694B2

  公开（公告）日：2009-12-22